SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-032413
Filing Date
2021-12-23
Accepted
2021-12-23 17:00:14
Documents
13
Period of Report
2021-12-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45144
2 ex16-1.htm EX-16.1 5162
  Complete submission text file 0001493152-21-032413.txt   220253

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE otlc-20211221.xsd EX-101.SCH 3036
4 XBRL LABEL FILE otlc-20211221_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE otlc-20211221_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3293
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 211517797
SIC: 2834 Pharmaceutical Preparations